Health Care Professionals
- Reporting Forms
- Webinars
- Guidance
Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children, ATS/IDSA/CDC
Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis, ATS/ISSA/CDC
Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020
